[go: up one dir, main page]

SE9504267D0 - New therapeutic use - Google Patents

New therapeutic use

Info

Publication number
SE9504267D0
SE9504267D0 SE9504267A SE9504267A SE9504267D0 SE 9504267 D0 SE9504267 D0 SE 9504267D0 SE 9504267 A SE9504267 A SE 9504267A SE 9504267 A SE9504267 A SE 9504267A SE 9504267 D0 SE9504267 D0 SE 9504267D0
Authority
SE
Sweden
Prior art keywords
pct
therapeutic use
new therapeutic
sec
date
Prior art date
Application number
SE9504267A
Other languages
English (en)
Swedish (sv)
Inventor
Herbert Helander
Joergen Ekstroem
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9504267A priority Critical patent/SE9504267D0/xx
Publication of SE9504267D0 publication Critical patent/SE9504267D0/xx
Priority to ZA969586A priority patent/ZA969586B/xx
Priority to ARP960105229A priority patent/AR004330A1/es
Priority to DK96940220T priority patent/DK0866699T3/da
Priority to US08/750,825 priority patent/US5962503A/en
Priority to DE69620786T priority patent/DE69620786T2/de
Priority to JP52040697A priority patent/JP4113257B2/ja
Priority to ES96940220T priority patent/ES2175153T3/es
Priority to AU77160/96A priority patent/AU718661B2/en
Priority to CA002237335A priority patent/CA2237335C/en
Priority to CN96199706A priority patent/CN1207679A/zh
Priority to EP96940220A priority patent/EP0866699B1/en
Priority to AT96940220T priority patent/ATE216235T1/de
Priority to PT96940220T priority patent/PT866699E/pt
Priority to CN2008101459688A priority patent/CN101380320B/zh
Priority to PCT/SE1996/001531 priority patent/WO1997019685A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
SE9504267A 1995-11-29 1995-11-29 New therapeutic use SE9504267D0 (sv)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE9504267A SE9504267D0 (sv) 1995-11-29 1995-11-29 New therapeutic use
ZA969586A ZA969586B (en) 1995-11-29 1996-11-14 The use of cholinesterase inhibitors in the treatment of xerostomia
ARP960105229A AR004330A1 (es) 1995-11-29 1996-11-18 Uso de inhibidores de colinesterasa en el tratamiento de xerostomia
PCT/SE1996/001531 WO1997019685A1 (en) 1995-11-29 1996-11-25 The use of cholinesterase inhibitors in the treatment of xerostomia
JP52040697A JP4113257B2 (ja) 1995-11-29 1996-11-25 口腔乾燥症の処理におけるコリンエステラーゼ阻害剤の使用
US08/750,825 US5962503A (en) 1995-11-29 1996-11-25 Use of cholinesterase inhibitors in the treatment of xerostomia
DE69620786T DE69620786T2 (de) 1995-11-29 1996-11-25 Verwendung von cholinesterase-inhibitoren für die herstellung eines medikaments zur behandlung von xerostomie
DK96940220T DK0866699T3 (da) 1995-11-29 1996-11-25 Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi
ES96940220T ES2175153T3 (es) 1995-11-29 1996-11-25 Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.
AU77160/96A AU718661B2 (en) 1995-11-29 1996-11-25 The use of cholinesterase inhibitors in the treatment of xerostomia
CA002237335A CA2237335C (en) 1995-11-29 1996-11-25 The use of cholinesterase inhibitors in the treatment of xerostomia
CN96199706A CN1207679A (zh) 1995-11-29 1996-11-25 用胆碱酯酶抑制剂治疗口腔干燥症
EP96940220A EP0866699B1 (en) 1995-11-29 1996-11-25 The use of cholinesterase inhibitors for the manufacture of a medicament for the treatment of xerostomia
AT96940220T ATE216235T1 (de) 1995-11-29 1996-11-25 Verwendung von cholinesterase-inhibitoren für die herstellung eines medikaments zur behandlung von xerostomie
PT96940220T PT866699E (pt) 1995-11-29 1996-11-25 Utilizacao de inibidores de colinesterase para o fabrico de um medicamento para o tratamento de xerostomia
CN2008101459688A CN101380320B (zh) 1995-11-29 1996-11-25 胆碱酯酶抑制剂的制药用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9504267A SE9504267D0 (sv) 1995-11-29 1995-11-29 New therapeutic use

Publications (1)

Publication Number Publication Date
SE9504267D0 true SE9504267D0 (sv) 1995-11-29

Family

ID=20400405

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9504267A SE9504267D0 (sv) 1995-11-29 1995-11-29 New therapeutic use

Country Status (14)

Country Link
US (1) US5962503A (pt)
EP (1) EP0866699B1 (pt)
JP (1) JP4113257B2 (pt)
CN (2) CN101380320B (pt)
AR (1) AR004330A1 (pt)
AT (1) ATE216235T1 (pt)
AU (1) AU718661B2 (pt)
DE (1) DE69620786T2 (pt)
DK (1) DK0866699T3 (pt)
ES (1) ES2175153T3 (pt)
PT (1) PT866699E (pt)
SE (1) SE9504267D0 (pt)
WO (1) WO1997019685A1 (pt)
ZA (1) ZA969586B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102403A1 (en) * 2001-06-14 2002-12-27 Novo Nordisk A/S Mucosal repair by tff dimer peptides
JP2006070027A (ja) * 2004-08-06 2006-03-16 Dai Ichi Seiyaku Co Ltd 口腔粘膜投与剤
US20060263414A1 (en) * 2005-05-19 2006-11-23 Pauline Pan Confectionery products for the treatment of dry mouth
US20070077300A1 (en) * 2005-09-30 2007-04-05 Wynn David W Oral compositions containing a salivation inducing agent
US9161909B2 (en) * 2007-08-24 2015-10-20 Axiomedic Ltd. Adhesive compositions for the treatment of xerostomia
US20090053309A1 (en) * 2007-08-24 2009-02-26 Axiomedic Ltd., Gibraltar Adhesive compositions for the treatment of xerostomia
CN114010575B (zh) * 2021-10-22 2024-06-28 江苏谛奇医药科技有限公司 新斯的明及其衍生物的新制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187165A (en) * 1987-05-15 1993-02-16 Hoechst-Roussel Pharmaceuticals Inc. Memory enhancing and analgesic 1,2,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b]indoles
SE9103752D0 (sv) * 1991-12-18 1991-12-18 Astra Ab New compounds
US5387614A (en) * 1993-07-27 1995-02-07 University Of Iowa Research Foundation Use of sigma receptor ligands as salivary gland stimulants

Also Published As

Publication number Publication date
WO1997019685A1 (en) 1997-06-05
EP0866699A1 (en) 1998-09-30
ATE216235T1 (de) 2002-05-15
ZA969586B (en) 1997-05-29
DK0866699T3 (da) 2002-08-12
ES2175153T3 (es) 2002-11-16
DE69620786T2 (de) 2002-11-21
EP0866699B1 (en) 2002-04-17
JP2000508618A (ja) 2000-07-11
DE69620786D1 (de) 2002-05-23
AR004330A1 (es) 1998-11-04
PT866699E (pt) 2002-08-30
US5962503A (en) 1999-10-05
AU718661B2 (en) 2000-04-20
CN101380320B (zh) 2010-12-29
CN1207679A (zh) 1999-02-10
JP4113257B2 (ja) 2008-07-09
AU7716096A (en) 1997-06-19
CN101380320A (zh) 2009-03-11

Similar Documents

Publication Publication Date Title
SE9500422D0 (sv) New oral pharmaceutical dosage forms
SE9600072D0 (sv) New oral formulation of two active ingredients II
SE9504661D0 (sv) New compounds
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
NO970067D0 (no) Nytt farmasöytisk preparat for smertebehandling
SE9401728D0 (sv) New compounds II
ATE193442T1 (de) 3,4-diarylchromane zur behandlung von dermatitis
EE9700366A (et) Angiotensiini II tüüp 1 retseptori antagonistide kasutamine düspeptiliste sümptomite profülaktikas ja/või ravis kasutatava ravimi valmistamiseks ja angiotensiini II tüüp 1 retseptori antagoniste sisaldavad ravimpreparaadid
SE9504267D0 (sv) New therapeutic use
DE69516671D1 (de) Verbindungen mit analgetischem und lokalanesthetischem effekt
CO4940452A1 (es) Modificacion a cristal de una sustancia activa de medicamen- to
FI963394A0 (fi) Yskää vastustava koostumus, joka sisältää yskää vastustavaa ainetta ja bentsydamiinia
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
AU1081695A (en) The use of an ester of inositoltrisphosphate for the preparing of medicaments
SE9302218D0 (sv) New use
PT862454E (pt) Novas utilizacoes de ctla-8 de mamifero e reagentes relacionados
PT740657E (pt) 4-aril-isoindois com actividade analgesica
TR199701604T2 (xx) Pirol t�revleri i�in yeni ba�vuru
SE9603284D0 (sv) New compounds
CA2237335A1 (en) The use of cholinesterase inhibitors in the treatment of xerostomia
NO307204B1 (no) Anvendelse av riluzol ved fremstilling av medikamenter ved behandling av stråleskader
DE69428276D1 (de) Insulinähnlicher wachstumfaktor ii als antitumormittel
AU5870298A (en) 1,4-dihydropyridin derivatives and their use in therapy
SE9802075D0 (sv) New use
UA10754A (uk) Спосіб лікуваhhя артеріальhих гіпертеhзій різhого геhезу